Dr. Reddy's Laboratories (RDY) Is Up Sharply After FDA Approval
Dr. Reddy's Laboratories (RDY) announced after the bell Thursday that it has received approval from the FDA for Buprenorphine and Naloxone Sublingual Film, a generic version of Suboxone.
Source: RTTNews
Tesla (Nasdaq: TSLA) Announces Date for First Quarter 2021 Financial Results and Webcast




